Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

DarioHealth (DRIO) Other Non Operating Income (2016 - 2025)

DarioHealth filings provide 13 years of Other Non Operating Income readings, the most recent being -$1.7 million for Q4 2025.

  • On a quarterly basis, Other Non Operating Income rose 88.71% to -$1.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$3.2 million, a 81.95% increase, with the full-year FY2025 number at -$1.9 million, up 55.08% from a year prior.
  • Other Non Operating Income hit -$1.7 million in Q4 2025 for DarioHealth, down from -$49000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $236000.0 in Q2 2021 to a low of -$15.3 million in Q4 2024.
  • Median Other Non Operating Income over the past 5 years was -$313000.0 (2024), compared with a mean of -$1.7 million.
  • The widest YoY moves for Other Non Operating Income: up 100.0% in 2021, down 371.3% in 2021.
  • DarioHealth's Other Non Operating Income stood at $47000.0 in 2021, then surged by 85.11% to $87000.0 in 2022, then tumbled by 5680.46% to -$4.9 million in 2023, then plummeted by 214.29% to -$15.3 million in 2024, then surged by 88.71% to -$1.7 million in 2025.
  • The last three reported values for Other Non Operating Income were -$1.7 million (Q4 2025), -$49000.0 (Q3 2025), and -$204000.0 (Q2 2025) per Business Quant data.